Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung.

PubWeight™: 1.63‹?› | Rank: Top 4%

🔗 View Article (PMC 3237757)

Published in Nano Lett on October 27, 2011

Authors

Matthew C Duch1, G R Scott Budinger, Yu Teng Liang, Saul Soberanes, Daniela Urich, Sergio E Chiarella, Laura A Campochiaro, Angel Gonzalez, Navdeep S Chandel, Mark C Hersam, Gökhan M Mutlu

Author Affiliations

1: Department of Medicine, Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, United States.

Articles citing this

In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. ACS Nano (2012) 1.53

Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett (2012) 1.40

Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites. Proc Natl Acad Sci U S A (2013) 1.28

Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black. Part Fibre Toxicol (2013) 1.17

Carbon-based nanomaterials: multifunctional materials for biomedical engineering. ACS Nano (2013) 1.11

Preparation and functionalization of graphene nanocomposites for biomedical applications. Nat Protoc (2013) 1.10

In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. Biomaterials (2012) 1.07

Recent advances in graphene family materials toxicity investigations. J Nanopart Res (2012) 1.04

In vitro evaluation of the effects of graphene platelets on glioblastoma multiforme cells. Int J Nanomedicine (2013) 1.02

Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy. Theranostics (2014) 0.96

Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. ACS Nano (2015) 0.94

Graphene oxide enhances cellular delivery of hydrophilic small molecules by co-incubation. ACS Nano (2014) 0.92

Mechanisms of Gadographene-Mediated Proton Spin Relaxation. J Phys Chem C Nanomater Interfaces (2013) 0.88

An in vitro evaluation of graphene oxide reduced by Ganoderma spp. in human breast cancer cells (MDA-MB-231). Int J Nanomedicine (2014) 0.87

In vivo compatibility of graphene oxide with differing oxidation states. ACS Nano (2015) 0.83

Is graphene a promising nano-material for promoting surface modification of implants or scaffold materials in bone tissue engineering? Tissue Eng Part B Rev (2014) 0.83

Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle. Expert Opin Drug Deliv (2015) 0.83

Toxicity of pristine graphene in experiments in a chicken embryo model. Int J Nanomedicine (2014) 0.83

Graphene-Induced Adsorptive and Optical Artifacts During In Vitro Toxicology Assays. Small (2013) 0.81

Biodistribution and toxicity of radio-labeled few layer graphene in mice after intratracheal instillation. Part Fibre Toxicol (2016) 0.81

Evaluation of pulmonary and systemic toxicity following lung exposure to graphite nanoplates: a member of the graphene-based nanomaterial family. Part Fibre Toxicol (2016) 0.81

Graphene oxide attenuates Th2-type immune responses, but augments airway remodeling and hyperresponsiveness in a murine model of asthma. ACS Nano (2014) 0.80

Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80

Detection and quantification of 2H and 3R phases in commercial graphene-based materials. Carbon N Y (2015) 0.80

Differences in the Toxicological Potential of 2D versus Aggregated Molybdenum Disulfide in the Lung. Small (2015) 0.79

Graphene films show stable cell attachment and biocompatibility with electrogenic primary cardiac cells. Mol Cells (2013) 0.79

Identification and Optimization of Carbon Radicals on Hydrated Graphene Oxide for Ubiquitous Antibacterial Coatings. ACS Nano (2016) 0.79

Toxicity Evaluation of Graphene Oxidein Kidneys of Sprague-Dawley Rats. Int J Environ Res Public Health (2016) 0.79

Exceedingly biocompatible and thin-layered reduced graphene oxide nanosheets using an eco-friendly mushroom extract strategy. Int J Nanomedicine (2015) 0.78

Direct optical imaging of graphene in vitro by nonlinear femtosecond laser spectral reshaping. Nano Lett (2012) 0.78

Fate and Transport of Molybdenum Disulfide Nanomaterials in Sand Columns. Environ Eng Sci (2015) 0.78

Toxicology of chemically modified graphene-based materials for medical application. Arch Toxicol (2014) 0.77

Right or left: the role of nanoparticles in pulmonary diseases. Int J Mol Sci (2014) 0.77

Biological interactions and safety of graphene materials. MRS Bull (2012) 0.77

Effects of graphene oxide nanosheets on the ultrastructure and biophysical properties of the pulmonary surfactant film. Nanoscale (2015) 0.77

Synthesis, toxicity, biocompatibility, and biomedical applications of graphene and graphene-related materials. Int J Nanomedicine (2016) 0.77

Stability and Transport of Graphene Oxide Nanoparticles in Groundwater and Surface Water. Environ Eng Sci (2014) 0.77

Biofabrication of a novel biomolecule-assisted reduced graphene oxide: an excellent biocompatible nanomaterial. Int J Nanomedicine (2016) 0.77

Toxicology of graphene-based nanomaterials. Adv Drug Deliv Rev (2016) 0.77

Facilitating Translational Nanomedicine via Predictive Safety Assessment. Mol Ther (2017) 0.77

Colloidal properties and stability of aqueous suspensions of few-layer graphene: Importance of graphene concentration. Environ Pollut (2016) 0.76

Biological and environmental interactions of emerging two-dimensional nanomaterials. Chem Soc Rev (2016) 0.76

Toxicology Study of Single-walled Carbon Nanotubes and Reduced Graphene Oxide in Human Sperm. Sci Rep (2016) 0.75

Preparation and tumor cell model based biobehavioral evaluation of the nanocarrier system using partially reduced graphene oxide functionalized by surfactant. Int J Nanomedicine (2015) 0.75

High-Concentration Aqueous Dispersions of Nanoscale 2D Materials Using Nonionic, Biocompatible Block Copolymers. Small (2015) 0.75

Deposition of graphene nanomaterial aerosols in human upper airways. J Occup Environ Hyg (2016) 0.75

Toxicity of graphene-family nanoparticles: a general review of the origins and mechanisms. Part Fibre Toxicol (2016) 0.75

Graphene oxide and reduced graphene oxide induced neural pheochromocytoma-derived PC12 cell lines apoptosis and cell cycle alterations via the ERK signaling pathways. Int J Nanomedicine (2017) 0.75

Differences in inflammation and acute phase response but similar genotoxicity in mice following pulmonary exposure to graphene oxide and reduced graphene oxide. PLoS One (2017) 0.75

Structure Activity Relationships of Engineered Nanomaterials in inducing NLRP3 Inflammasome Activation and Chronic Lung Fibrosis. NanoImpact (2016) 0.75

In vivo noninvasive analysis of graphene nanomaterial pharmacokinetics using photoacoustic flow cytometry. J Appl Toxicol (2017) 0.75

Articles cited by this

Raman spectrum of graphene and graphene layers. Phys Rev Lett (2006) 16.04

Graphene: status and prospects. Science (2009) 11.73

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A (2010) 8.12

Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am J Physiol Lung Cell Mol Physiol (2005) 7.28

Processable aqueous dispersions of graphene nanosheets. Nat Nanotechnol (2008) 7.10

Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci (2003) 6.95

Large-area ultrathin films of reduced graphene oxide as a transparent and flexible electronic material. Nat Nanotechnol (2008) 6.32

Preparation and characterization of graphene oxide paper. Nature (2007) 6.28

Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol Sci (2003) 5.73

Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem (2004) 5.26

Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J Biol Chem (2004) 4.75

Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett (2006) 4.44

PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. J Am Chem Soc (2008) 4.11

Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A (2006) 3.86

Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am J Physiol Lung Cell Mol Physiol (2008) 3.80

Nano-Graphene Oxide for Cellular Imaging and Drug Delivery. Nano Res (2008) 3.80

Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett (2010) 3.59

Raman spectra of graphite oxide and functionalized graphene sheets. Nano Lett (2007) 2.83

Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J Am Chem Soc (2011) 2.36

Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest (2007) 2.36

Recombinant human Fas ligand induces alveolar epithelial cell apoptosis and lung injury in rabbits. Am J Physiol Lung Cell Mol Physiol (2001) 2.16

Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int J Biochem Cell Biol (2005) 2.12

Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano (2010) 2.05

In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. ACS Nano (2010) 1.94

Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med (2010) 1.84

Graphene oxide, highly reduced graphene oxide, and graphene: versatile building blocks for carbon-based materials. Small (2010) 1.83

Efficient elimination of inhaled nanoparticles from the alveolar region: evidence for interstitial uptake and subsequent reentrainment onto airways epithelium. Environ Health Perspect (2007) 1.65

Mitochondrial complex III-generated oxidants activate ASK1 and JNK to induce alveolar epithelial cell death following exposure to particulate matter air pollution. J Biol Chem (2008) 1.37

Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ. Am J Respir Crit Care Med (2011) 1.34

Reduction of graphene oxide via bacterial respiration. ACS Nano (2010) 1.33

Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis. Free Radic Biol Med (2010) 1.29

Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett (2010) 1.22

Proapoptotic Noxa is required for particulate matter-induced cell death and lung inflammation. FASEB J (2009) 1.01

Emerging Methods for Producing Monodisperse Graphene Dispersions. J Phys Chem Lett (2010) 0.89

Articles by these authors

Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A (2010) 8.12

Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature (2011) 6.57

Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab (2005) 5.61

Physiological roles of mitochondrial reactive oxygen species. Mol Cell (2012) 5.05

Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity (2013) 4.08

AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature (2012) 3.85

Sorting carbon nanotubes by electronic structure using density differentiation. Nat Nanotechnol (2006) 3.66

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell (2004) 3.62

The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol (2007) 3.47

Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci (2010) 3.17

Hypoxic but not anoxic stabilization of HIF-1alpha requires mitochondrial reactive oxygen species. Am J Physiol Lung Cell Mol Physiol (2002) 2.90

Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal (2013) 2.78

Circadian clock NAD+ cycle drives mitochondrial oxidative metabolism in mice. Science (2013) 2.49

Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol (2007) 2.45

The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev (2011) 2.38

Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J Clin Invest (2007) 2.36

Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab (2011) 2.21

Colloidal properties and stability of graphene oxide nanomaterials in the aquatic environment. Environ Sci Technol (2013) 2.19

Hypoxia-induced endocytosis of Na,K-ATPase in alveolar epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta. J Clin Invest (2003) 2.14

Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation. J Natl Cancer Inst (2005) 2.10

Rethinking antioxidants in the intensive care unit. Am J Respir Crit Care Med (2013) 2.05

Hypoxia. 2. Hypoxia regulates cellular metabolism. Am J Physiol Cell Physiol (2010) 2.03

Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol (2005) 1.97

PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a). Proc Natl Acad Sci U S A (2008) 1.92

Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am J Respir Cell Mol Biol (2013) 1.90

Epithelial cell death is an important contributor to oxidant-mediated acute lung injury. Am J Respir Crit Care Med (2010) 1.84

Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance. Am J Respir Crit Care Med (2004) 1.79

Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med (2009) 1.78

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration. Nat Cell Biol (2011) 1.77

Carbon nanomaterials for electronics, optoelectronics, photovoltaics, and sensing. Chem Soc Rev (2013) 1.77

Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia. Mol Cell Biol (2007) 1.71

Effective passivation of exfoliated black phosphorus transistors against ambient degradation. Nano Lett (2014) 1.70

A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure. Eur Heart J (2015) 1.68

Emerging device applications for semiconducting two-dimensional transition metal dichalcogenides. ACS Nano (2014) 1.64

Targeting glucose metabolism for cancer therapy. J Exp Med (2012) 1.64

Mitochondrial ROS initiate phosphorylation of p38 MAP kinase during hypoxia in cardiomyocytes. Am J Physiol Lung Cell Mol Physiol (2002) 1.63

Solution phase production of graphene with controlled thickness via density differentiation. Nano Lett (2009) 1.61

Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.61

Proapoptotic Bid is required for pulmonary fibrosis. Proc Natl Acad Sci U S A (2006) 1.59

AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis. J Clin Invest (2008) 1.58

Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol (2009) 1.58

Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am J Respir Crit Care Med (2006) 1.57

Reactive oxygen species are required for hyperoxia-induced Bax activation and cell death in alveolar epithelial cells. J Biol Chem (2003) 1.55

The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol Cell (2013) 1.54

Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation. J Biol Chem (2004) 1.53

Hydrodynamic characterization of surfactant encapsulated carbon nanotubes using an analytical ultracentrifuge. ACS Nano (2008) 1.53

Enrichment of single-walled carbon nanotubes by diameter in density gradients. Nano Lett (2005) 1.51

Reactive oxygen species-dependent signaling regulates cancer. Cell Mol Life Sci (2009) 1.49

The cellular basis for diverse responses to oxygen. Free Radic Biol Med (2006) 1.47

Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways. Crit Care Med (2009) 1.46

Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation. Am J Respir Cell Mol Biol (2011) 1.44

Room-temperature molecular-resolution characterization of self-assembled organic monolayers on epitaxial graphene. Nat Chem (2009) 1.43

Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg (2006) 1.43

Pluronic F108 coating decreases the lung fibrosis potential of multiwall carbon nanotubes by reducing lysosomal injury. Nano Lett (2012) 1.40

Mitochondrial reactive oxygen species regulate transforming growth factor-β signaling. J Biol Chem (2012) 1.39

Compound C inhibits hypoxic activation of HIF-1 independent of AMPK. FEBS Lett (2007) 1.39

Alpha1-AMP-activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol (2009) 1.37

Mitochondrial complex III-generated oxidants activate ASK1 and JNK to induce alveolar epithelial cell death following exposure to particulate matter air pollution. J Biol Chem (2008) 1.37

Humanizing the mouse: in defense of murine models of critical illness. Am J Respir Crit Care Med (2013) 1.36

Colored semitransparent conductive coatings consisting of monodisperse metallic single-walled carbon nanotubes. Nano Lett (2008) 1.36

Bcl-2 family members and functional electron transport chain regulate oxygen deprivation-induced cell death. Mol Cell Biol (2002) 1.36

Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J Biol Chem (2009) 1.35

Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion. Biochim Biophys Acta (2010) 1.35

Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-γ. Am J Respir Crit Care Med (2011) 1.34

CNTF induces photoreceptor neuroprotection and Müller glial cell proliferation through two different signaling pathways in the adult zebrafish retina. Exp Eye Res (2009) 1.33

A chemical genomics screen highlights the essential role of mitochondria in HIF-1 regulation. Proc Natl Acad Sci U S A (2008) 1.33

Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. J Biol Chem (2002) 1.32

Menadione triggers cell death through ROS-dependent mechanisms involving PARP activation without requiring apoptosis. Free Radic Biol Med (2010) 1.29

Hypoxia-mediated degradation of Na,K-ATPase via mitochondrial reactive oxygen species and the ubiquitin-conjugating system. Circ Res (2006) 1.27